These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11493730)

  • 1. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
    Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
    Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
    Yazer MH; Podlosky L; Clarke G; Nahirniak SM
    Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
    Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
    Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
    King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
    Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
    Rajesh K; Harsh S; Amarjit K
    Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
    Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
    Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
    Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
    Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs and symptoms associated with the transfusion of WBC-reduced RBCs and non-WBC-reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study.
    Lane TA; Gernsheimer T; Mohandas K; Assmann SF
    Transfusion; 2002 Feb; 42(2):265-74. PubMed ID: 11896345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WBC reduction in RBC concentrates by prestorage filtration: multicenter experience.
    Yomtovian R; Gernsheimer T; Assmann SF; Mohandas K; Lee TH; Kalish LA; Busch MP;
    Transfusion; 2001 Aug; 41(8):1030-6. PubMed ID: 11493735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
    Wang RR; Triulzi DJ; Qu L
    Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of leukocyte-reduction on the transfusion reactions to red blood cells concentrates].
    Mukagatare I; Monfort M; de Marchin J; Gerard C
    Transfus Clin Biol; 2010 Feb; 17(1):14-9. PubMed ID: 20106700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.
    Heddle NM; Blajchman MA; Meyer RM; Lipton JH; Walker IR; Sher GD; Constantini LA; Patterson B; Roberts RS; Thorpe KE; Levine MN
    Transfusion; 2002 May; 42(5):556-66. PubMed ID: 12084163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prestorage WBC filtration of RBC units with soft-shell filters: filtration performance and impact on RBCs during storage for 42 days.
    Müller-Steinhardt M; Hennig H; Kirchner H; Schlenke P
    Transfusion; 2002 Feb; 42(2):153-8. PubMed ID: 11896328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
    Klüter H; Bubel S; Kirchner H; Wilhelm D
    Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients.
    Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L
    Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of RBC units and rate of transfusionto anemic HIV-positive patients assigned to receiveWBC-reduced or non-WBC-reduced RBCs: the viral activation transfusion study experience.
    Brecher ME; Triulzi DJ; Assmann SF;
    Transfusion; 2001 Jun; 41(6):794-8. PubMed ID: 11399822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of preventing febrile nonhemolytic transfusion reaction by leukocyte-depleted blood transfusion.
    Zhao SM; Cheng XL; Hu J; Xiang GC; Zhang JS; Li RQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):568-70. PubMed ID: 12513724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.